Page last updated: 2024-11-04

sumatriptan and Lung Neoplasms

sumatriptan has been researched along with Lung Neoplasms in 1 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Lung Neoplasms: Tumors or cancer of the LUNG.

Research Excerpts

ExcerptRelevanceReference
"Both sumatriptan and 5-HT inhibit adenylate cyclase activity at doses which correlate with the mitogenic effect."1.295-HT1D receptor type is involved in stimulation of cell proliferation by serotonin in human small cell lung carcinoma. ( Bondiolotti, G; Cattaneo, MG; Palazzi, E; Vicentini, LM, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cattaneo, MG1
Palazzi, E1
Bondiolotti, G1
Vicentini, LM1

Other Studies

1 other study available for sumatriptan and Lung Neoplasms

ArticleYear
5-HT1D receptor type is involved in stimulation of cell proliferation by serotonin in human small cell lung carcinoma.
    European journal of pharmacology, 1994, Aug-16, Volume: 268, Issue:3

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Carcinoma, Small Cell; Cell Division; Colforsin; Hum

1994